{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-033653","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.071635+00:00","generated_at":"2026-05-25T10:23:31.684900+00:00","sec_items":["4.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Xenon Pharmaceuticals dismisses KPMG, appoints PwC as independent auditor","bullets":["Audit Committee dismissed KPMG as independent registered public accounting firm on March 3, 2025.","No disagreements or reportable events with KPMG during 2024, 2023, or interim period through March 3, 2025.","Audit Committee approved engagement of PricewaterhouseCoopers LLP for fiscal year ending Dec 31, 2025.","No prior consultations with PwC regarding accounting principles or audit scope during the two most recent fiscal years."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-033653","json":"https://secwatch.observer/filing/0000950170-25-033653.json","markdown":"https://secwatch.observer/filing/0000950170-25-033653.md","text":"https://secwatch.observer/filing/0000950170-25-033653.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/0000950170-25-033653-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/xene-20250303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T10:23:31.684900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}